Cited 0 time in
L-PGDS Suppression Via L-PGDS-shRNA in Cerebral Ischemia/Reperfusion Injury
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Sohn, Ju-Tae | - |
| dc.date.accessioned | 2025-05-26T05:30:13Z | - |
| dc.date.available | 2025-05-26T05:30:13Z | - |
| dc.date.issued | 2025-11 | - |
| dc.identifier.issn | 1075-2765 | - |
| dc.identifier.issn | 1536-3686 | - |
| dc.identifier.uri | https://scholarworks.gnu.ac.kr/handle/sw.gnu/78576 | - |
| dc.description.abstract | [No abstract available] | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | Lippincott Williams & Wilkins Ltd. | - |
| dc.title | L-PGDS Suppression Via L-PGDS-shRNA in Cerebral Ischemia/Reperfusion Injury | - |
| dc.type | Article | - |
| dc.publisher.location | 미국 | - |
| dc.identifier.doi | 10.1097/MJT.0000000000001944 | - |
| dc.identifier.scopusid | 2-s2.0-105004436391 | - |
| dc.identifier.wosid | 001609826700036 | - |
| dc.identifier.bibliographicCitation | American Journal of Therapeutics, v.32, no.6, pp e548 - e548 | - |
| dc.citation.title | American Journal of Therapeutics | - |
| dc.citation.volume | 32 | - |
| dc.citation.number | 6 | - |
| dc.citation.startPage | e548 | - |
| dc.citation.endPage | e548 | - |
| dc.type.docType | Letter | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
| dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0532
COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
